Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2021-06-15 Capital/Financing Update
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a $6.4 million order book for a recently acquired business unit, discussing acquisition strategy, share capital, market overview, and forward-looking statements. It includes no detailed financial statements or comprehensive financial performance data. It is primarily an update on business activities, acquisitions, and financing plans, with some market and share capital information. It does not contain quarterly or annual financial reports, audit opinions, or earnings highlights. The document is longer than 5,000 characters and provides substantive business and financing updates, but it is not a formal financial report. It fits best as a Capital/Financing Update (CAP) because it discusses financing activities, acquisition strategy, share capital, and order book updates relevant to investors and the market.
2021-06-15 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Salona Global Medical Device Corporation has begun trading on the TSX Venture Exchange. It includes details about the company's share capital, concurrent financing, M&A pipeline, balance sheet, management team, and market opportunity. The document discusses the company's strategy for acquisitions and growth but does not contain any financial statements, detailed financial results, or regulatory filings. It is not an earnings release, annual report, or interim report. It is also not a regulatory filing or certification. The document is primarily an announcement about the commencement of trading and the company's strategic outlook, including financing and acquisition plans. This fits best under the category of Capital/Financing Update (CAP), as it provides updates on the company's capital structure, financing activities, and market listing status.
2021-06-09 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Salona Global Medical Device Corporation has received final approval from the TSX Venture Exchange for its Change of Business and commencement of trading. It includes details about the company's share capital, financing, M&A pipeline, market overview, and management commentary. The document does not contain actual financial statements or detailed financial performance data, nor is it a transcript or a regulatory filing with certifications. It is primarily an update on capital structure, financing, and business strategy related to the company's listing and future plans. This fits best under Capital/Financing Update (CAP) as it discusses share capital, financing rounds, and acquisition financing plans. The document length and content confirm it is not a brief announcement or a report publication announcement. Therefore, the classification is CAP with high confidence.
2021-06-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed press release announcing the completion of a change of business transaction (COB) by Salona Global Medical Device Corporation. It includes information about the transaction, share conversions, amendments to articles, appointments, and future business plans. The document is not a financial report, earnings release, or regulatory filing per se, but rather a comprehensive announcement about a significant corporate transaction and related corporate actions. It does not contain financial statements or detailed financial analysis, nor is it a proxy, voting result, or management report. The focus is on the completion of the change of business transaction and related corporate developments, which fits best under Capital/Financing Update (CAP) as it involves capital structure changes, share conversions, and financing-related transactions.
2021-06-05 English
News release - English.pdf
Regulatory Filings
2021-06-01 English
News release - English.pdf
Regulatory Filings
2021-05-27 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.